Cited by 82Sleep and Wakefulness ResearchTreatment of Major DepressionSleep and related disorders

Sleep and sleep electroencephalogram in depressed patients treated with phenelzine

Landolt, Hans-Peter, Raimo, Eric B., Schnierow, Bradley J., Kelsoe, John R., Rapaport, Mark H., Gillin, J. Christian·2001·Archives of General Psychiatry

Abstract

BACKGROUND: The beneficial effect of antidepressant interventions has been proposed to depend on suppression of rapid eye movement (REM) sleep or inhibition of electroencephalographic (EEG) slow-wave activity (SWA) in non-REM sleep. Use of the monoamine oxidase inhibitor phenelzine sulfate can eliminate REM sleep. We studied the relation between REM sleep suppression and antidepressant response and the effect of phenelzine therapy on sleep EEG power spectra. METHODS: Open-labeled prescriptions of 30 to 90 mg of phenelzine were given to 11 patients with major depressive disorder (6 men and 5 women; mean age, 41.4 years); all were physically healthy. Mood, dream recall, sleep, sleep EEG, and ocular and muscular activity during sleep were studied before treatment and during the third and fifth weeks of pharmacotherapy. RESULTS: Six patients remitted from depression, 2 responded partially, and 3 showed no antidepressant response. Independent from clinical response, REM sleep was dramatically suppressed. On average, only 4.9 minutes of REM sleep was observed in treatment week 5, and it was completely absent in 6 patients. This effect was compensated for by increased stage 2 sleep. In non-REM sleep, EEG power was higher than at baseline between 16.25 and 25 Hz. Slow-wave activity (power within 0.75-4.5 Hz) and the exponential decline of SWA during sleep were not affected. CONCLUSIONS: Antidepressant response to phenelzine treatment does not depend on elimination of REM sleep or inhibition of SWA in non-REM sleep. In depressed patients, REM sleep is regulated independently from non-REM sleep and can be manipulated without altering the dynamics of SWA.

Integrity signals

Registry

Crossref · 10.1001/archpsyc.58.3.268

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Pharmacologically induced REM sleep suppression does not affect dream recall.

    “REM sleep suppression pharmacologically-induced did not affect dream recall”

    From The Functional Role of Dreaming in Emotional Processes (2019) · cites this paper as Landolt et al., 2001

Cites

Flagged first, then by citations

1 of the 50 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Landolt, H.-P., Raimo, E. B., Schnierow, B. J., Kelsoe, J. R., Rapaport, M. H., & Gillin, J. C.
Affiliations
University of California San Diego (US)
Venue
Archives of General Psychiatry
Published
2001-03-01
Volume
58
Issue
3
Pages
268
ISSN
0003-990X (ISSN-L)
OpenAlex
W2123712104
Cited by
82
References
50
Citations by year
2026: 2 · 2025: 2 · 2024: 1 · 2023: 1 · 2022: 2 · 2021: 3 · 2020: 3 · 2019: 2 · 2018: 3 · 2017: 3 · 2016: 2 · 2015: 5 · 2014: 2 · 2013: 3 · 2012: 2
FWCI
2.79
Type
journal article
Language
en
Open access
closed
Locations
  • Archives of General Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r01mh038738-09)
  • National Institute of Mental Health (MH-38738, MH30914)
  • National Center for Research Resources (M-01RR00827, M01RR000827)
Topics
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Sleep and Wakefulness Research
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
Keywords
phenelzine, monoamine oxidase inhibitors, major depressive disorder, REM sleep suppression, slow-wave activity, antidepressant response, stage 2 sleep, dream recall
MeSH terms
Adult, Affect, Depressive Disorder, Dose-Response Relationship, Drug, Dreams, Electroencephalography, Female, Humans, Male, Middle Aged, Monoamine Oxidase Inhibitors, Phenelzine, Mental Recall, Sleep, Sleep, REM, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review